Regulatory Scrutiny Rattles Applovin Shares

Applovin Corporation faces regulatory pressure as the Securities and Exchange Commission launches an investigation into the company’s data collection practices. The mobile advertising technology firm, which had been enjoying a spectacular rally throughout 2024, saw its shares tumble 14% following the news before staging a partial recovery.

Market Volatility Follows Regulatory Disclosure

The investment community reacted sharply to Monday’s Bloomberg report revealing the SEC’s formal inquiry. According to sources, the investigation was prompted by whistleblower allegations and several short-seller reports questioning Applovin’s compliance with platform partner terms of service. The core allegation suggests the company may have violated partner agreements to enable more targeted advertising capabilities.

Tuesday’s trading session brought a notable rebound, with shares climbing 7.6% as analysts from Citigroup, Oppenheimer, and Wedbush characterized the market’s initial reaction as excessive. These firms maintained positive outlooks on the stock despite the regulatory developments. Weiss Ratings similarly reaffirmed its “Buy” recommendation.

Meanwhile, multiple law firms have announced they are examining potential securities fraud claims against the company.

Should investors sell immediately? Or is it worth buying Applovin?

Record-Setting Rally Faces Headwinds

The regulatory scrutiny emerges at a challenging moment for Applovin, which has delivered extraordinary shareholder returns. The stock had surged an impressive 700% during 2024 and had already advanced more than 80% in 2025, driven primarily by the success of its AI-powered advertising platform AXON. The company’s remarkable performance earned it inclusion in the prestigious S&P 500 index in September.

Criticism of Applovin’s data practices isn’t entirely new. Short-selling firms including Fuzzy Panda Research and Culper Research have repeatedly raised concerns about the company’s data handling methods in reports published over recent months. The timing is particularly noteworthy given Applovin’s recent rebranding to “Axon” on October 1, coupled with the launch of its Axon Ads Manager targeting the lucrative e-commerce sector. The very AI technology now under regulatory examination represents the cornerstone of this strategic expansion.

November Earnings in Focus

The potential consequences for Applovin remain uncertain, with possible outcomes ranging from financial penalties to mandated changes in business practices. The company has issued a brief statement indicating it “routinely communicates with regulatory bodies” but has not commented specifically on the investigation.

Market attention now turns to November 5, when Applovin is scheduled to release third-quarter financial results. Investors will scrutinize management’s commentary regarding the SEC probe for any indications of its potential impact on operations. Despite maintaining a “Moderate Buy” consensus on the stock, analysts may view recent insider selling activity with increased concern given the current regulatory environment.